15.41BMarket Cap-90826P/E (TTM)
20.960High19.010Low2.29MVolume20.160Open20.390Pre Close45.83MTurnover2.23%Turnover RatioLossP/E (Static)737.45MShares33.89052wk High35.17P/B2.15BFloat Cap1.79052wk Low--Dividend TTM102.77MShs Float33.890Historical High--Div YieldTTM9.56%Amplitude0.660Historical Low19.995Avg Price1Lot Size
Summit Therapeutics Stock Forum
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet